Alpine Global Management, LLC Fulcrum Therapeutics, Inc. Transaction History

Alpine Global Management, LLC

  • $331 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$5.98 - $9.31 $358,698 - $558,441
59,983 New
59,983 $371,000
Q4 2022

Feb 14, 2023
BUY
$5.01 - $8.35 $80,525 - $134,209
16,073 New
16,073 $117,000
Q1 2022

May 13, 2022
SELL
$9.96 - $23.65 $208,213 - $494,403
-20,905 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$14.0 - $28.44 $292,670 - $594,538
20,905 New
20,905 $370,000

Others Institutions Holding FULC

# of Institutions
150
Shares Held
52.2M
Call Options Held
6.91M
Put Options Held
1.9M
View Full List

About Fulcrum Therapeutics, Inc.

FULC Quotes by TradingView
  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $237M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email